Derek T. Chalmers, President & CEO at Cara Therapeutics, Inc. (CARA), sold 11,799 shares at $16.00 ($189K) on 2020-11-17, disclosed to the SEC on 2020-11-19.
Seasonal sale ($189k) by President & CEO — this insider has traded CARA in November in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| CARA | SELL | 2021-03-08 | $112K | — | Filing → |
| CARA | SELL | 2021-02-25 | $453K | — | Filing → |
| CARA | SELL | 2020-12-30 | $186K | — | Filing → |